论文部分内容阅读
针对不同靶点药物联合应用药效相加的规律和精确计算协同/相加/拮抗效应通用方法的建立
【机 构】
:
军事医学科学院二所 北京市太平路27 号 100850
【出 处】
:
2016医学科学前沿暨第四届个体化治疗与抗肿瘤药物研究新趋向研讨会
【发表日期】
:
2016年10期
其他文献
Objective: Doxorubicin is a widely used antineoplastic agent in clinics for treating a wide range of cancers.However,the clinical use is largely limited by its cardiotoxicity of the heart.DS-36 is a n
Hepatocellular carcinoma(HCC)is the sixth most frequent malignant tumor with poor prognosis,and its clinical therapeutic outcome is poor.Volasertib,a potent small molecular inhibitor of polo-like kina
会议
Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorecta
Regorafenib significantly prolongs overall survival in patients with metastatic colorectal cancer(mCRC),but the overall clinical efficacy of regorafenib remains quite limited.Combination chemotherapy
会议
Effect of abemaciclib(LY2835219)on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexp
Multidrug resistance(MDR)is the major obstacle of the success in cancer chemotherapy.The overexpression of ATP-binding cassette(ABC)transporters,particularly ABCB1,ABCC1 and ABCG2,play a significant r
OP16,a novel derivative of oridonin,potentiates the antitumor effect of rapamycin by inhibiting rapa
Backgrounds and Purpose: Rapamycin,an mTORC1 allosteric inhibitor with broad antitumor effects,could induce the activation of numerous negative feedback loops such as PI3K/Akt/mTOR signaling pathway,w
会议
目的:食管癌(Esophageal carcinoma,EC)是消化道发病率最高的恶性肿瘤,易扩散转移,我国的食管癌发病率在肿瘤中高居第四。肿瘤多药耐药严重影响化疗效果,甚至导致化疗失败。因此,阐明食管癌转移及化疗耐受的分子机制,筛选鉴定相关标志物,对其进行靶向干预逆转,对提高食管癌治疗效果具有重要的理论价值和应用前景。
目的:研究2-甲氧基雌二醇(2-ME)的衍生物抗肿瘤血管生成的作用。方法:利用鸡胚尿囊膜法筛选2-ME 衍生物;用MTT 法对筛选出的衍生物进行细胞毒测定;用划痕实验和Transwell 小室迁移实验检测衍生物对HUVEC 细胞和MCF-7 细胞的迁移和侵袭的影响;裸鼠移植瘤实验考察体内抗肿瘤作用,并探讨衍生物抗肿瘤的作用机制。
Backgroud: Overexpression of c-Myc is associated with worse outcomes in endometrial cancer,indicating that c-Myc may be a promising target for endometrial cancer therapy.A novel small molecule,JQ1,has